Depleting interferon regulatory factor‐1(IRF‐1) with CRISPR/Cas9 attenuates inducible oxidative metabolism without affecting RA‐induced differentiation in HL‐60 human AML cells-Reference-Cited by-同舟云学术

Depleting interferon regulatory factor‐1(IRF‐1) with CRISPR/Cas9 attenuates inducible oxidative metabolism without affecting RA‐induced differentiation in HL‐60 human AML cells

Published:2020-05-22 Issue:6 Volume:2 Page:354-364
ISSN:2573-9832
Container-title:FASEB BioAdvances
language:en
Short-container-title:FASEB BioAdvances

Author:

Zhu Kaiyuan¹²³,Yue Jianbo²³,Yen Andrew¹

Affiliation:

1. Department of Biomedical Sciences Cornell University Ithaca NY USA

2. City University of Hong Kong ShenZhen Research Institute ShenZhen China

3. Department of Biomedical Sciences City University of Hong Kong Hong Kong China

Funder

National Institutes of Health

National Natural Science Foundation of China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fba.2020-00004

Reference48 articles.

1. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins

2. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3

3. Retinoic Acid Therapy Resistance Progresses from Unilineage to Bilineage in HL-60 Leukemic Blasts

4. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vacuolin-1 enhances RA-induced differentiation of human myeloblastic leukemia cells: evidence for involvement of a CD11b/FAK/LYN/SLP-76 axis subject to endosomal regulation that drives late differentiation steps;Cell & Bioscience;2022-11-03

2. The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia;Biomedical Papers;2021-09-20